{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,21]],"date-time":"2026-04-21T22:46:35Z","timestamp":1776811595369,"version":"3.51.2"},"reference-count":46,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,2,23]],"date-time":"2022-02-23T00:00:00Z","timestamp":1645574400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neurolog\u00eda (English Edition)"],"published-print":{"date-parts":[[2023,3]]},"DOI":"10.1016\/j.nrleng.2020.06.013","type":"journal-article","created":{"date-parts":[[2022,3,3]],"date-time":"2022-03-03T16:52:46Z","timestamp":1646326366000},"page":"75-81","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Epidemiology of myasthenia gravis in the province of Ourense (Galicia, Spain)"],"prefix":"10.1016","volume":"38","author":[{"given":"D.A.","family":"Garc\u00eda Est\u00e9vez","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.M.","family":"L\u00f3pez D\u00edaz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Pardo Parrado","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.","family":"P\u00e9rez Lorenzo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N.A.","family":"Sabbagh Casado","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.","family":"Ozaita Arteche","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.","family":"Rodr\u00edguez G\u00f3mez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.nrleng.2020.06.013_bib0005","doi-asserted-by":"crossref","first-page":"2570","DOI":"10.1056\/NEJMra1602678","article-title":"Myasthenia gravis","volume":"375","author":"Gilhus","year":"2016","journal-title":"N Engl J Med."},{"key":"10.1016\/j.nrleng.2020.06.013_bib0010","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1016\/S1474-4422(15)00145-3","article-title":"Myasthenia gravis: subgroup classification and therapeutic strategies","volume":"14","author":"Gilhus","year":"2015","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.nrleng.2020.06.013_bib0015","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1186\/1471-2377-10-46","article-title":"A systematic review of population based epidemiological studies in Myasthenia Gravis","volume":"10","author":"Carr","year":"2010","journal-title":"BMC Neurol."},{"key":"10.1016\/j.nrleng.2020.06.013_bib0020","doi-asserted-by":"crossref","first-page":"419","DOI":"10.3349\/ymj.2016.57.2.419","article-title":"The epidemiology of yastehenia gravis in Korea","volume":"57","author":"Lee","year":"2016","journal-title":"Yonsei Med J."},{"key":"10.1016\/j.nrleng.2020.06.013_bib0025","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1212\/WNL.47.5.1233","article-title":"Epidemiologic evidence for a changing natural history of myasthenia gravis","volume":"47","author":"Phillips","year":"1996","journal-title":"Neurology."},{"key":"10.1016\/j.nrleng.2020.06.013_bib0030","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1196\/annals.1254.053","article-title":"The epidemiology of Myasthenia Gravis","volume":"998","author":"Phillips","year":"2003","journal-title":"Ann NY Acad Sci."},{"key":"10.1016\/j.nrleng.2020.06.013_bib0035","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1055\/s-2004-829593","article-title":"The epidemiology of myasthenia gravis","volume":"24","author":"Phillips","year":"2004","journal-title":"Semin Neurol."},{"key":"10.1016\/j.nrleng.2020.06.013_bib0040","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1159\/000279334","article-title":"The incidence of Myasthenia Gravis: a systematic literature review","volume":"34","author":"McGrogan","year":"2003","journal-title":"Neuroepidemiology."},{"key":"10.1016\/j.nrleng.2020.06.013_bib0045","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1212\/01.wnl.0000176067.32186.a3","article-title":"Increasing incidence of late-onset anti-ach antibody-seropositive myasthenia gravis","volume":"65","author":"Somnier","year":"2005","journal-title":"Neurology."},{"key":"10.1016\/j.nrleng.2020.06.013_bib0050","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1093\/ageing\/25.1.56","article-title":"Myasthenia gravis and elderly people","volume":"25","author":"Shon","year":"1996","journal-title":"Age Aging."},{"key":"10.1016\/j.nrleng.2020.06.013_bib0055","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1002\/mus.23964","article-title":"Late-onset myasthenia gravis: a review when incidence in older adults keeps increasing","volume":"48","author":"Alkhawajah","year":"2013","journal-title":"Muscle Nerve."},{"key":"10.1016\/j.nrleng.2020.06.013_bib0060","first-page":"196","article-title":"Myasthenia Gravis: a disease of the very old","volume":"62","author":"Aragon\u00e8s","year":"2014","journal-title":"Neurology."},{"key":"10.1016\/j.nrleng.2020.06.013_bib0065","doi-asserted-by":"crossref","first-page":"1526","DOI":"10.1212\/WNL.0b013e318217e735","article-title":"Increasing incidence of myasthenia gravis among elderly in British Columbia, Canada","volume":"76","author":"Pakzad","year":"2011","journal-title":"Neurology."},{"key":"10.1016\/j.nrleng.2020.06.013_bib0070","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1136\/jnnp.74.8.1105","article-title":"Evidence of underdiagnosis of myasthenia gravis in older people","volume":"74","author":"Vincet","year":"2003","journal-title":"J Neurol Neurosurg Psychiatry."},{"key":"10.1016\/j.nrleng.2020.06.013_bib0075","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1111\/j.1468-1331.2012.03698.x","article-title":"A national epidemiological study of Myasthenia gravis in Australia","volume":"19","author":"Gattellari","year":"2012","journal-title":"Eur J Neurol."},{"key":"10.1016\/j.nrleng.2020.06.013_bib0080","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1212\/WNL.55.1.16","article-title":"Myasthenia gravis. Recommendations for clinical research standars","volume":"55","author":"Task force of the Medical Scientific Advisory Board of the Myasthenia gravis Foundation of America","year":"2000","journal-title":"Neurology."},{"key":"10.1016\/j.nrleng.2020.06.013_bib0085","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1111\/ene.13535","article-title":"A nationwide epidemiological study of myasthenia gravis in Latvia","volume":"25","author":"Zieda","year":"2018","journal-title":"Eur J Neurol."},{"issue":"espec congr","key":"10.1016\/j.nrleng.2020.06.013_bib0090","first-page":"1176","article-title":"Prevalencia de la Miastenia gravis en la provincia de Cuenca","volume":"214","author":"Quintero-L\u00f3pez","year":"2014","journal-title":"Rev Clin Esp."},{"key":"10.1016\/j.nrleng.2020.06.013_bib0095","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1002\/mus.25068","article-title":"Epidemiolgy os Myasthenia gravis in Northern Portugal: frequency estimates and clinical epidemiological distribution of cases","volume":"54","author":"Santos","year":"2016","journal-title":"Muscle Nerve."},{"key":"10.1016\/j.nrleng.2020.06.013_bib0100","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.nrl.2014.09.007","article-title":"Prevalencia de miastenia gravis en la comarca de Osona (Barcelona, Catalu\u00f1a)","volume":"32","author":"Aragon\u00e8s","year":"2017","journal-title":"Neurolog\u00eda."},{"key":"10.1016\/j.nrleng.2020.06.013_bib0105","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.nmd.2015.10.009","article-title":"Epidemiology of myasthenia gravis in Ontorio, Canada","volume":"26","author":"Breiner","year":"2016","journal-title":"Neuromuscul Dis."},{"key":"10.1016\/j.nrleng.2020.06.013_bib0110","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1111\/ane.12270","article-title":"Myasthenia gravis incidence in a general North Atlantic isolated population","volume":"130","author":"Joensen","year":"2014","journal-title":"Acta Neurol Scand."},{"key":"10.1016\/j.nrleng.2020.06.013_bib0115","series-title":"Epidemiolog\u00eda y caracter\u00edsticas cl\u00ednicas de la miastenia gravis en la comarca de la Marina Baixa, Alicante. (Tesis doctotal)","author":"D\u00edaz-Mart\u00edn","year":"2013"},{"key":"10.1016\/j.nrleng.2020.06.013_bib0120","doi-asserted-by":"crossref","first-page":"340","DOI":"10.3988\/jcn.2016.12.3.340","article-title":"Incidence and prevalence of myasthenia gravis in Korea: a population-based study using the National Health Insurance claims database","volume":"12","author":"Park","year":"2016","journal-title":"J Clin Neurol."},{"key":"10.1016\/j.nrleng.2020.06.013_bib0125","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1159\/000328863","article-title":"Change in myasthenia gravis epidemiology in Trento, Italy, after twenty years","volume":"36","author":"Pallaver","year":"2011","journal-title":"Neuroepidemiology."},{"key":"10.1016\/j.nrleng.2020.06.013_bib0130","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1159\/000311012","article-title":"Nationwide population-based epidemiological study of myasthenia gravis in Taiwan","volume":"35","author":"Lai","year":"2010","journal-title":"Neuroepidemiology."},{"key":"10.1016\/j.nrleng.2020.06.013_bib0135","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1002\/mus.23271","article-title":"Geographical distribution of a seropositive myasthenia gravis population","volume":"45","author":"Heldal","year":"2012","journal-title":"Muscle Nerve."},{"key":"10.1016\/j.nrleng.2020.06.013_bib0140","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1159\/000080093","article-title":"Incidence of myasthenia gravis in the province of Ferrara: a community-based study","volume":"23","author":"Casetta","year":"2004","journal-title":"Neuroepidemiology."},{"key":"10.1016\/j.nrleng.2020.06.013_bib0145","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1136\/jnnp.65.4.492","article-title":"Myasthenia gravis: a population based epidemiological study in Cambridgeshire, England","volume":"65","author":"Robertson","year":"1998","journal-title":"J Neurol Neurosurg Psychiatry."},{"key":"10.1016\/j.nrleng.2020.06.013_bib0150","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1136\/jnnp.71.3.352","article-title":"Epidemiology of seropositive myasthenia gravis in Greece","volume":"71","author":"Poulas","year":"2000","journal-title":"J Neurol Neurosurg Psychiatry."},{"key":"10.1016\/j.nrleng.2020.06.013_bib0155","first-page":"2068","article-title":"Prevalencia de la miastenia gravis en la isla de La Palma","volume":"25","author":"Villagra-Cocco","year":"1997","journal-title":"Rev Neurol."},{"key":"10.1016\/j.nrleng.2020.06.013_bib0160","first-page":"435","article-title":"Some epidemiological aspects of myasthenia gravis in Cuba","volume":"24","author":"Cisneros","year":"1996","journal-title":"Rev Neurol."},{"key":"10.1016\/j.nrleng.2020.06.013_bib0165","doi-asserted-by":"crossref","first-page":"1779","DOI":"10.1212\/WNL.43.9.1779","article-title":"Incidence and prevalence of myasthenia gravis in western Denmark: 1975 to 1989","volume":"43","author":"Christensen","year":"1993","journal-title":"Neurology."},{"key":"10.1016\/j.nrleng.2020.06.013_bib0170","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1001\/archneur.1991.00530190081019","article-title":"Epidemiology of myasthenia gravis in Denmark. A longitudinal and comprehensive population survey","volume":"48","author":"Somnier","year":"1991","journal-title":"Arch Neurol."},{"key":"10.1016\/j.nrleng.2020.06.013_bib0175","doi-asserted-by":"crossref","first-page":"1638","DOI":"10.1136\/jnnp.74.12.1638","article-title":"A population based epidemiological study on myasthenia gravis in Estonia","volume":"74","author":"\u00d6\u00f6pik","year":"2003","journal-title":"J Neurol Neurosurg Psychiatry."},{"key":"10.1016\/j.nrleng.2020.06.013_bib0180","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1212\/WNL.42.10.1888","article-title":"The epidemiology of myasthenia gravis in central and western Virginia","volume":"42","author":"Phillips","year":"1992","journal-title":"Neurology."},{"key":"10.1016\/j.nrleng.2020.06.013_bib0185","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1111\/j.1600-0404.1984.tb00825.x","article-title":"Epidemiology of myasthenia gravis in Norway","volume":"70","author":"Storm-Mathisen","year":"1984","journal-title":"Acta Neurol Scand."},{"key":"10.1016\/j.nrleng.2020.06.013_bib0190","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/B978-0-12-386960-9.00002-2","article-title":"Vitamin D and innate and adaptative immunity","volume":"86","author":"Hewison","year":"2011","journal-title":"Vitam Horm."},{"key":"10.1016\/j.nrleng.2020.06.013_bib0195","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/j.jocn.2018.01.047","article-title":"Low serum vitamin D levels in patients with myasthenia gravis","volume":"50","author":"Kang","year":"2018","journal-title":"J Clin Neurosci."},{"key":"10.1016\/j.nrleng.2020.06.013_bib0200","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1586\/1744666X.2015.1047345","article-title":"The role of T regulatory cells in immunopathogenesis of myasthenia gravis: implications for therapeutics","volume":"11","author":"Alahgholi-Hajibehzad","year":"2015","journal-title":"Expert Rev Clin Immunol."},{"key":"10.1016\/j.nrleng.2020.06.013_bib0205","doi-asserted-by":"crossref","first-page":"1554","DOI":"10.1111\/j.1468-1331.2012.03773.x","article-title":"Vitamin D deficiency in patients with myasthenia gravis and improvement of fatigue after suplemmentation of vitamin D3: a pilot study","volume":"19","author":"Askmark","year":"2012","journal-title":"Eur J Neurol."},{"key":"10.1016\/j.nrleng.2020.06.013_bib0210","doi-asserted-by":"crossref","first-page":"47","DOI":"10.33588\/rn.6401.2016367","article-title":"Mejor\u00eda cl\u00ednica e inmunol\u00f3gica de miastenia grave tras tratamiento con denosumab","volume":"64","author":"Rodr\u00edguez-G\u00f3mez","year":"2017","journal-title":"Rev Neurol."},{"key":"10.1016\/j.nrleng.2020.06.013_bib0215","doi-asserted-by":"crossref","first-page":"51","DOI":"10.12659\/AJCR.894849","article-title":"Remission of severe myasthenia gravis after massive-dose vitamin D treatment","volume":"17","author":"Cadegiami","year":"2016","journal-title":"Am J Case Rep."},{"key":"10.1016\/j.nrleng.2020.06.013_bib0220","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1111\/j.1468-1331.2007.01978.x","article-title":"Clinical features of patients with myasthenia gravis associated with autoimmune diseases","volume":"14","author":"Kanazawa","year":"2007","journal-title":"Eur J Neurol."},{"key":"10.1016\/j.nrleng.2020.06.013_bib0225","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1111\/j.1600-0404.1989.tb03881.x","article-title":"Associeted disorders in myasthenia gravis: autoimmune diseases and their relation to thymectomy","volume":"80","author":"Thorlacius","year":"1989","journal-title":"Acta Neurol Scand."},{"key":"10.1016\/j.nrleng.2020.06.013_bib0230","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1111\/j.1600-0404.1995.tb00432.x","article-title":"Associated autoinmmune diseases in myasthenia gravis. A population-based study","volume":"91","author":"Christensen","year":"1995","journal-title":"Acta Neurol Scand."}],"container-title":["Neurolog\u00eda (English Edition)"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S217358082200013X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S217358082200013X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T03:35:44Z","timestamp":1761881744000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S217358082200013X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3]]},"references-count":46,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2023,3]]}},"alternative-id":["S217358082200013X"],"URL":"https:\/\/doi.org\/10.1016\/j.nrleng.2020.06.013","relation":{},"ISSN":["2173-5808"],"issn-type":[{"value":"2173-5808","type":"print"}],"subject":[],"published":{"date-parts":[[2023,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Epidemiology of myasthenia gravis in the province of Ourense (Galicia, Spain)","name":"articletitle","label":"Article Title"},{"value":"Neurolog\u00eda (English Edition)","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nrleng.2020.06.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/j.nrl.2020.06.011","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Sociedad Espa\u00f1ola de Neurolog\u00eda. Published by Elsevier Espa\u00f1a, S.L.U.","name":"copyright","label":"Copyright"}]}}